Safety and efficacy of statins in patients with end-stage renal disease.

about

High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?Special considerations for the treatment of chronic kidney disease in the elderly.

P2860

Q35942023-C9F64D85-44B4-45B2-9914-DAD3DF4449D7 Q38737061-E6ABCEFD-278E-4954-BC93-539E9A3E30F6

P2860

Safety and efficacy of statins in patients with end-stage renal disease.

Item

http://www.wikidata.org/entity/Q38164683

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Safety and efficacy of statins in patients with end-stage renal disease.

@en

type

Item

label

Safety and efficacy of statins in patients with end-stage renal disease.

@en

prefLabel

Safety and efficacy of statins in patients with end-stage renal disease.

@en

P1476

Safety and efficacy of statins in patients with end-stage renal disease.

@en

P2093

Carol L Moore

http://www.w3.org/2001/XMLSchema#string

Carrie W Nemerovski

http://www.w3.org/2001/XMLSchema#string

Jona Lekura

http://www.w3.org/2001/XMLSchema#string

Michelle Cefaretti

http://www.w3.org/2001/XMLSchema#string

Pooja T Mehta

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

Rosuvastatin and cardiovascular events in patients undergoing hemodialysis.

Statin-associated myopathy.

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

Safety of statins: focus on clinical pharmacokinetics and drug interactions.

Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

The safety of statins in clinical practice.

Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis

P304

1321-1329

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1060028013501997

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24259696

http://www.w3.org/2001/XMLSchema#string

Safety and efficacy of statins in patients with end-stage renal disease.

about

P2860

P2860

Safety and efficacy of statins in patients with end-stage renal disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698